PMB 200 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pmb 200, and when can generic versions of Pmb 200 launch?
Pmb 200 is a drug marketed by Wyeth Ayerst and is included in one NDA.
The generic ingredient in PMB 200 is estrogens, conjugated; meprobamate. There are three drug master file entries for this compound. Additional details are available on the estrogens, conjugated; meprobamate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PMB 200?
- What are the global sales for PMB 200?
- What is Average Wholesale Price for PMB 200?
Summary for PMB 200
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 26 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PMB 200 at DailyMed |
US Patents and Regulatory Information for PMB 200
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Wyeth Ayerst | PMB 200 | estrogens, conjugated; meprobamate | TABLET;ORAL | 010971-005 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PMB 200
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Wyeth Ayerst | PMB 200 | estrogens, conjugated; meprobamate | TABLET;ORAL | 010971-005 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PMB 200
See the table below for patents covering PMB 200 around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Argentina | 042345 | UN PROCEDIMIENTO PARA LA PREPARACION DE UNA COMPOSICION FARMACEUTICA PARA EL TRATAMIENTO DE ATEROSCLEROSIS QUE CONTIENE 8.9 - DEHIDROESTERONA O SUS SALES DE LA MISMA | ⤷ Sign Up |
South Korea | 100256861 | ⤷ Sign Up | |
Japan | H07504197 | ⤷ Sign Up | |
European Patent Office | 0864583 | Esters de sulfate de 8,9-dehydro-estrone de métal alcalin (Alkali metal 8,9-dehydroestrone sulfate esters) | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |